# VIDAZA

NDC: 59572-102
Generic name: azacitidine
Labeler / Manufacturer: Celgene Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20040705

FDA application: NDA050794

## Active ingredients

- AZACITIDINE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59572-102"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59572-102
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3495a71a-cc04-4776-851f-f185956f32af